We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-1.37%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.2B
AUM Growth
+$2.05B
Cap. Flow
+$2.63B
Cap. Flow %
18.56%
Top 10 Hldgs %
24.41%
Holding
915
New
139
Increased
425
Reduced
186
Closed
46

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$226M
2
MSFT icon
Microsoft
MSFT
+$205M
3
TSLA icon
Tesla
TSLA
+$83.2M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$65.6M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$64.9M

Top Sells

Rank Stock Value
1
SQM icon
Sociedad Química y Minera de Chile
SQM
+$60.4M
2
META icon
Meta Platforms (Facebook)
META
+$39.1M
3
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
+$36.9M
4
BKNG icon
Booking.com
BKNG
+$28M
5
SYK icon
Stryker
SYK
+$25.2M

Sector Composition

Rank Sector Weight
1 Healthcare 31.77%
2 Technology 24.47%
3 Financials 9.64%
4 Consumer Discretionary 7.95%
5 Industrials 7.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SRE icon
326
Sempra
SRE
$58.1B
$7.21M 0.05%
96,096
+4,310
+5% +$349K
NSC icon
327
Norfolk Southern
NSC
$75.4B
$7.2M 0.05%
34,349
+18,006
+110% +$4.33M
OPLN
328
Openlane
OPLN
$4.28B
$7.13M 0.05%
+638,662
New +$9.59M
CBRE icon
329
CBRE Group
CBRE
$43.3B
$7.08M 0.05%
104,928
+61,786
+143% +$4.9M
FIS icon
330
Fidelity National Information Services
FIS
$24.2B
$7M 0.05%
92,589
+48,549
+110% +$4.52M
FOLD
331
DELISTED
Amicus Therapeutics
FOLD
$6.98M 0.05%
668,879
-170,000
-20% -$1.89M
BSY icon
332
Bentley Systems
BSY
$11.2B
$6.92M 0.05%
226,219
+58,199
+35% +$2.13M
CHTR icon
333
Charter Communications
CHTR
$17.3B
$6.9M 0.05%
22,740
+11,384
+100% +$4.87M
TRV icon
334
Travelers Companies
TRV
$81.1B
$6.88M 0.05%
44,898
+16,367
+57% +$2.66M
CLH icon
335
Clean Harbors
CLH
$17.2B
$6.84M 0.05%
62,156
+26,150
+73% +$2.8M
T icon
336
AT&T
T
$164B
$6.8M 0.05%
443,552
-42,681
-9% -$777K
AVLR
337
DELISTED
Avalara, Inc.
AVLR
$6.6M 0.05%
+71,907
New +$6.44M
DLO icon
338
dLocal
DLO
$4.29B
$6.47M 0.05%
315,200
+84,000
+36% +$2.23M
RLMD icon
339
Relmada Therapeutics
RLMD
$540M
$6.46M 0.05%
174,605
+32,419
+23% +$898K
INDA icon
340
iShares MSCI India ETF
INDA
$6.81B
$6.32M 0.04%
154,860
+49,660
+47% +$2.1M
VCYT icon
341
Veracyte
VCYT
$4.45B
$6.29M 0.04%
378,663
– –
VEEV icon
342
Veeva Systems
VEEV
$33.8B
$6.28M 0.04%
38,077
-6,533
-15% -$1.31M
WST icon
343
West Pharmaceutical
WST
$23.7B
$6.28M 0.04%
25,505
-31,798
-55% -$9.69M
SWCH
344
DELISTED
Switch, Inc. Class A Common Stock
SWCH
$6.1M 0.04%
181,083
+55,245
+44% +$1.87M
ORCL icon
345
Oracle
ORCL
$339B
$6.09M 0.04%
99,721
-41,716
-29% -$3.05M
AIG icon
346
American International
AIG
$42.5B
$6.08M 0.04%
128,138
+61,959
+94% +$3.25M
GE icon
347
GE Aerospace
GE
$364B
$6.06M 0.04%
157,190
+2,730
+2% +$120K
BNS icon
348
Scotiabank
BNS
$105B
$5.98M 0.04%
125,041
+97,480
+354% +$5.57M
PRU icon
349
Prudential Financial
PRU
$42.6B
$5.96M 0.04%
69,491
+25,170
+57% +$2.42M
MKL icon
350
Markel Group
MKL
$25.2B
$5.84M 0.04%
+5,387
New +$6.57M
12 13
14
15 16

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Candriam SCA's Q3 2022 Portfolio in Review

As of Q3 2022, Candriam SCA held 915 positions worth $14.2B, up 17% from $12.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Candriam SCA deployed $2.63B of net new capital in Q3 2022, opening 139 new positions and adding to 425 existing holdings. Its largest new stake was Veru: 378,115 shares worth $43.6M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 34% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Sociedad Química y Minera de Chile, an estimated $60.4M trimmed.

  • Candriam SCA's largest Q3 2022 buy was Veru: 378,115 shares worth $43.6M.
  • Candriam SCA added most to Apple in Q3 2022, an estimated $226M increase.
  • Candriam SCA's biggest Q3 2022 reduction was Sociedad Química y Minera de Chile, cutting an estimated $60.4M.
  • Candriam SCA fully exited Turning Point Therapeutics, Inc. Common Stock in Q3 2022, selling an estimated $36.9M.
  • Candriam SCA's ten largest holdings make up 24% of its $14.2B portfolio in Q3 2022.
  • Candriam SCA opened 139 new positions and closed 46 in Q3 2022.
  • Candriam SCA's portfolio value rose 17% quarter-over-quarter to $14.2B.

Based on Candriam SCA's 13F filing for Q3 2022, filed 10 Nov 2022.